Vitamin D metabolism in human adipose tissue: could it explain low vitamin D status in obesity?

[1] Lenders CM, Feldman HA, Von Scheven E, Merewood A, Sweeney C, Wilson DM, et al. Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr. 2009;90:459–67.10.3945/ajcn.2008.27275Search in Google Scholar PubMed PubMed Central

[2] Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94:67–73.10.1210/jc.2008-1575Search in Google Scholar PubMed PubMed Central

[3] Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009;94:3306–13.10.1210/jc.2009-0079Search in Google Scholar PubMed PubMed Central

[4] Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010;59:242–8.10.2337/db09-1011Search in Google Scholar PubMed PubMed Central

[5] Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr. 2010;92:1344–9.10.3945/ajcn.110.000976Search in Google Scholar PubMed PubMed Central

[6] Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D status, adiposity, and lipids in Black American and Caucasian children. J Clin Endocrinol Metab. 2011;96:1560–7.10.1210/jc.2010-2388Search in Google Scholar PubMed PubMed Central

[7] Rajakumar K, de las Heras J, Lee S, Holick MF, Arslanian SA. 25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and beta-cell function relative to insulin sensitivity in Black and White youth. Diabetes Care. 2012;35:627–33.10.2337/dc11-1825Search in Google Scholar PubMed PubMed Central

[8] Nguyen VT, Li X, Elli EF, Ayloo SM, Castellanos KJ, Fantuzzi G, et al. Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity. Obesity (Silver Spring). 2015;23:1591–7.10.1002/oby.21131Search in Google Scholar PubMed

[9] Clemente-Postigo M, Munoz-Garach A, Serrano M, Garrido-Sanchez L, Bernal-Lopez MR, Fernandez-Garcia D, et al. Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2015;100:E591–5.10.1210/jc.2014-3016Search in Google Scholar PubMed

[10] Khan RJ, Riestra P, Gebreab SY, Wilson JG, Gaye A, Xu R, et al. Vitamin D receptor gene polymorphisms are associated with abdominal visceral adipose tissue volume and serum adipokine concentrations but not with body mass index or waist circumference in African Americans: the Jackson Heart Study. J Nutr. 2016;146:1476–82.10.3945/jn.116.229963Search in Google Scholar PubMed PubMed Central

[11] Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue - the effect of obesity and diet-induced weight loss. Int J Obes (Lond). 2013;37:651–7.10.1038/ijo.2012.112Search in Google Scholar PubMed

[12] Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28:1228–30.10.2337/diacare.28.5.1228Search in Google Scholar PubMed

[13] Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.10.1210/jc.2011-0385Search in Google Scholar PubMed

[14] Huh SY, Gordon CM. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord. 2008;9:161–70.10.1007/s11154-007-9072-ySearch in Google Scholar PubMed

[15] Weng FL, Shults J, Leonard MB, Stallings VA, Zemel BS. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr. 2007;86:150–8.10.1093/ajcn/86.1.150Search in Google Scholar PubMed

[16] Fry CM, Sanders TA. Vitamin D and risk of CVD: a review of the evidence. Proc Nutr Soc. 2015;74:245–57.10.1017/S0029665115000014Search in Google Scholar PubMed

[17] Landrier JF, Karkeni E, Marcotorchino J, Bonnet L, Tourniaire F. Vitamin D modulates adipose tissue biology: possible consequences for obesity?. Proc Nutr Soc. 2016;75:38–46.10.1017/S0029665115004164Search in Google Scholar PubMed

[18] Malmberg P, Karlsson T, Svensson H, Lonn M, Carlsson NG, Sandberg AS, et al. A new approach to measuring vitamin D in human adipose tissue using time-of-flight secondary ion mass spectrometry: a pilot study. J Photochem Photobiol B. 2014;138:295–301.10.1016/j.jphotobiol.2014.06.008Search in Google Scholar PubMed

[19] Wamberg L, Pedersen SB, Rejnmark L, Richelsen B. Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity: a review. Curr Obes Rep. 2015;4:429–40.10.1007/s13679-015-0176-5Search in Google Scholar PubMed

[20] Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al. Vitamin D(3) in fat tissue. Endocrine. 2008;33:90–4.10.1007/s12020-008-9051-4Search in Google Scholar PubMed PubMed Central

[21] Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr. 2012;108:1915–23.10.1017/S0007114512003285Search in Google Scholar PubMed

[22] Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008;57:183–91.10.1016/j.metabol.2007.08.023Search in Google Scholar PubMed

[23] Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26–34.10.1210/jc.2008-1454Search in Google Scholar PubMed PubMed Central

[24] Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726–76.10.1210/er.2008-0004Search in Google Scholar PubMed PubMed Central

[25] Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 2012;93:82–90.10.1016/j.yexmp.2012.04.006Search in Google Scholar PubMed PubMed Central

[26] Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S–88.10.1093/ajcn/80.6.1678SSearch in Google Scholar PubMed

[27] Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab. 2006;290:E916–24.10.1152/ajpendo.00410.2005Search in Google Scholar PubMed

[28] Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev. 2006;64:479–86.10.1111/j.1753-4887.2006.tb00180.xSearch in Google Scholar PubMed

[29] Shen L, Zhuang QS, Ji HF. Assessment of vitamin D levels in type 1 and type 2 diabetes patients: results from metaanalysis. Mol Nutr Food Res. 2016;60:1059–67.10.1002/mnfr.201500937Search in Google Scholar PubMed

[30] Trochoutsou AI, Kloukina V, Samitas K, Xanthou G. Vitamin-D in the immune system: genomic and non-genomic actions. Mini Rev Med Chem. 2015;15:953–63.10.2174/1389557515666150519110830Search in Google Scholar PubMed

[31] Ulutas O, Taskapan H, Taskapan MC, Temel I. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Nephrol. 2013;45:879–84.10.1007/s11255-012-0308-8Search in Google Scholar PubMed

[32] Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008;4:404–12.10.1038/ncprheum0855Search in Google Scholar PubMed

[33] Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011;57:63–9.10.1161/HYPERTENSIONAHA.110.160929Search in Google Scholar PubMed PubMed Central

[34] Pourshahidi LK. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc. 2015;74:115–24.10.1017/S0029665114001578Search in Google Scholar PubMed

[35] Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3.10.1093/ajcn/72.3.690Search in Google Scholar PubMed

[36] Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444–8.10.1038/oby.2011.404Search in Google Scholar PubMed

[37] Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25:543–59.10.1016/j.beem.2011.05.010Search in Google Scholar PubMed

[38] Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601–7.10.1210/jc.2004-0432Search in Google Scholar PubMed

[39] Fan JG, Farrell GC. VAT fat is bad for the liver, SAT fat is not!. J Gastroenterol Hepatol. 2008;23:829–32.10.1111/j.1440-1746.2008.05474.xSearch in Google Scholar PubMed

[40] Lemieux S. Contribution of visceral obesity to the insulin resistance syndrome. Can J Appl Physiol. 2001;26:273–90.10.1139/h01-018Search in Google Scholar PubMed

[41] Kato S. The function of vitamin D receptor in vitamin D action. J Biochem. 2000;127:717–22.10.1093/oxfordjournals.jbchem.a022662Search in Google Scholar PubMed

[42] Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542–8.10.1210/en.2006-0946Search in Google Scholar PubMed

[43] Zhao Y, Liao S, He J, Jin Y, Fu H, Chen X, et al. Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. Lipids Health Dis. 2014;13:129.10.1186/1476-511X-13-129Search in Google Scholar PubMed PubMed Central

[44] Beydoun MA, Tanaka T, Beydoun HA, Ding EL, Ferrucci L, Zonderman AB. Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults. J Nutr Sci. 2013;2:e33.10.1017/jns.2013.19Search in Google Scholar PubMed PubMed Central

[45] Cheon CK, Nam HK, Lee KH, Kim SY, Song JS, Kim C. Vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in a Korean population. Pediatr Int. 2015;57:870–4.10.1111/ped.12634Search in Google Scholar PubMed

[46] Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11:134–9.10.1080/13685530802273426Search in Google Scholar PubMed

[47] Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;44:235–41.10.1016/j.arcmed.2013.02.002Search in Google Scholar PubMed

[48] Ochs-Balcom HM, Chennamaneni R, Millen AE, Shields PG, Marian C, Trevisan M, et al. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93:5–10.10.3945/ajcn.2010.29986Search in Google Scholar PubMed PubMed Central

[49] Schuch NJ, Garcia VC, Vivolo SR, Martini LA. Relationship between vitamin D receptor gene polymorphisms and the components of metabolic syndrome. Nutr J. 2013;12:96.10.1186/1475-2891-12-96Search in Google Scholar PubMed PubMed Central

[50] Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001;145:181–6.10.1530/eje.0.1450181Search in Google Scholar PubMed

[51] Taylor HA, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, Garrison RJ, et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis. 2005;15:S6-4-17.Search in Google Scholar

[52] Aiba I, Yamasaki T, Shinki T, Izumi S, Yamamoto K, Yamada S, et al. Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases. Steroids. 2006;71:849–56.10.1016/j.steroids.2006.04.009Search in Google Scholar PubMed

[53] Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem. 2003;278:38084–93.10.1074/jbc.M307028200Search in Google Scholar PubMed PubMed Central

[54] Gupta RP, Hollis BW, Patel SB, Patrick KS, Bell NH. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res. 2004;19:680–8.10.1359/JBMR.0301257Search in Google Scholar PubMed

[55] Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523:9–18.10.1016/j.abb.2011.11.003Search in Google Scholar PubMed

[56] Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011;1814:186–99.10.1016/j.bbapap.2010.06.022Search in Google Scholar PubMed

[57] Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K. Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun. 2004;324:451–7.10.1016/j.bbrc.2004.09.073Search in Google Scholar PubMed

[58] Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888–94.10.1210/jcem.86.2.7220Search in Google Scholar

[59] Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004;101:7711–5.10.1073/pnas.0402490101Search in Google Scholar PubMed PubMed Central

[60] Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci. 1972;43:413–31.10.1042/cs0430413Search in Google Scholar PubMed

[61] Pereira CD, Azevedo I, Monteiro R, Martins MJ. 11beta-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14:869–81.10.1111/j.1463-1326.2012.01582.xSearch in Google Scholar PubMed